TerminatedNCT01772641
A Smoking Intervention Study Using Scheduled Gradual Reduction With Varenicline to Help With Cessation
Placebo comparisonAges 18+United StatesAddiction
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- New YorkSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateDecember 2012
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 32
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Sponsor type
- University
- Study type
- Other
- Intervention type
- OTHER
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT01772641
- Official title
Show the full official title
A Combination of Scheduled Reduced Smoking With Varenicline to Enhance Cessation
Recruitment & locations
TerminatedNew York
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Icahn School of Medicine at Mount Sinai, a university.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as terminated.
